Optimized combination of antiplatelet treatment and anticoagulation for percutaneous coronary intervention: The final word is not out yet!

Journal of Invasive Cardiology

Volumn 14, Issue 5, 2002, Pages 251-253

  Gruberg, Luis ^a   Beyar, Rafael ^a  

^a RAMBAM MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ABCIXIMAB; ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; CLOPIDOGREL; ENOXAPARIN; EPTIFIBATIDE; FIBRINOGEN RECEPTOR ANTAGONIST; LOW MOLECULAR WEIGHT HEPARIN; TICLOPIDINE; TIROFIBAN;

ACUTE HEART INFARCTION; CLINICAL TRIAL; CORONARY ARTERY DISEASE; DRUG EFFICACY; HUMAN; NOTE; Q WAVE; SUDDEN DEATH; TRANSLUMINAL CORONARY ANGIOPLASTY; UNSTABLE ANGINA PECTORIS;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ANTICOAGULANTS; CORONARY ARTERIOSCLEROSIS; DRUG THERAPY, COMBINATION; HUMANS; PLATELET AGGREGATION INHIBITORS; POSTOPERATIVE COMPLICATIONS; STENTS;

EID: 0036246264     PISSN: 10423931     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Note

References (7)

1. Thrombi in acute coronary syndromes. Revisited and revised
2. ESPRIT in context: Pharmacology matters!
3. Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: The PCI-CURE study
4. Percutaneous coronary intervention after subcutaneous enoxaparin pretreatment in patients with unstable angina pectoris
5. Low-molecular-weight heparin therapy in percutaneous coronary intervention: The NICE 1 and NICE 4 Trials
6. Enoxaparin and abciximab adjunctive pharmacotherapy during percutaneous coronary intervention
7. Use of clopidogrel loading, enoxaparin, and double bolus eptifibatide in the stetting of early percutaneous coronary intervention for acute coronary syndromes